

Naomi Osaka has turned tournament apparel into a documented part of her public tennis profile, using walk-on garments, performance kits, and luxury fashion appearances to connect heritage references with women’s sports style. Her Wimbledon entrance offered a clear example, pairing ceremony with match-day function under the tournament’s all-white rules. Key Takeaways Naomi Osaka wore a white Japanese-inspired walk-on garment before her June 29, 2026 Wimbledon first-round match against Elsa Jacquemot. Reuters reported that Osaka defeated Jacquemot 6-1, 7-5 after entering Court 3 in a Hana Yagi design with cranes and cherry blossoms. Nike’s 2024 U.S. Open collaboration with Yoon Ahn gave Osaka custom day and night competition kits with walk-on layers and oversized bows. Vogue reported in 2021 that Osaka wore a custom Louis Vuitton Met Gala look created with Nicolas Ghesquière and her sister, Mari. Public biographies note that Osaka was born in Japan to a Haitian father and Japanese mother. Naomi Osaka opened Wimbledon on June 29, 2026, with a walk-on look that placed heritage references inside one of tennis’s most controlled visual settings. Reuters reported that Osaka arrived on Court 3 in an all-white garment designed by Tokyo-based Hana Yagi before facing France’s Elsa Jacquemot. The

Perimenopause heart health concerns are receiving renewed attention after researchers identified evidence that cardiovascular changes in women may begin earlier than many physicians previously recognized. The findings emerged from a large-scale study examining metabolic and vascular indicators among women transitioning into menopause, with researchers observing measurable shifts in cholesterol, blood sugar regulation, and blood vessel function during the perimenopausal stage. The study focused on women who had not yet reached menopause but were already experiencing hormonal fluctuations associated with the transition period. Researchers analyzed cardiovascular markers over time and found that several risk indicators linked to heart disease appeared before menopause officially began. The findings are prompting additional discussion among medical professionals about earlier screening and preventive care strategies for women entering midlife. Heart disease remains one of the leading causes of death among women globally. While menopause has long been associated with increased cardiovascular risk, the latest findings suggest the biological changes contributing to that risk may start years earlier than previously emphasized in clinical practice. Researchers involved in the study examined how shifting estrogen levels during perimenopause may influence vascular function, inflammation, and metabolic health. The research adds to a growing body of evidence connecting hormonal changes to

PMOS checks could become more consistent under new draft guidance from the National Institute for Health and Care Excellence, which calls for closer assessment of women and girls with irregular periods, hormone-related symptoms, and related long-term health risks. The guidance is still under consultation, with final publication scheduled for December 2026. Key Takeaways NICE draft guidance calls for PMOS checks in people aged 10 and over with suspected symptoms. PMOS is the new name for polycystic ovary syndrome, previously known as PCOS. Irregular periods, androgen-related symptoms, and metabolic health concerns are central to the guidance. NICE recommends annual reviews for people diagnosed with PMOS. The draft consultation runs from July 1 to August 11, 2026. PMOS, or polyendocrine metabolic ovarian syndrome, is the newer name for the condition long known as polycystic ovary syndrome. The name change was formally introduced in May 2026 after international medical groups said the older term placed too much emphasis on ovarian cysts and did not fully describe the condition’s endocrine and metabolic features. The National Institute for Health and Care Excellence, known as NICE, has now published draft guidance on PMOS for consultation. The draft runs from July 1 to August 11, 2026,